ID: ALA2261617

Max Phase: Preclinical

Molecular Formula: C14H7ClN4O4

Molecular Weight: 330.69

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C1C(Nc2ccc([N+](=O)[O-])cc2)=C(Cl)C(=O)c2ncncc21

Standard InChI:  InChI=1S/C14H7ClN4O4/c15-10-12(18-7-1-3-8(4-2-7)19(22)23)13(20)9-5-16-6-17-11(9)14(10)21/h1-6,18H

Standard InChI Key:  QOASPUCDOKZVGF-UHFFFAOYSA-N

Associated Targets(Human)

HCT-15 51914 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

XF498 12972 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SK-MEL-2 46422 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SK-OV-3 52876 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 330.69Molecular Weight (Monoisotopic): 330.0156AlogP: 2.33#Rotatable Bonds: 3
Polar Surface Area: 115.09Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.62CX Basic pKa: CX LogP: 1.20CX LogD: 1.20
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.68Np Likeness Score: -0.96

References

1. Ryu C, Yi Y, Choi IH, Chae MJ, Han J, Jung O, Lee C.  (2004)  Synthesis and Cytotoxic Activity of 6-(Substituted-Phenyl)Amino-5,8-Quinazolinediones,  13  (5): [10.1007/s00044-004-0032-8]

Source